K

Kriya Therapeutics

Develops gene therapies; licenses collaborations

Manager – Computer Software Assurance & Validation

Regulatory & Quality (Life Sciences)Updated on Nov 14
Full-timeResearch Triangle Park, Durham, NC, USANo salary listed

About the Job

Requirements

  • A bachelor's degree in engineering or a life-science-related field is required.
  • At least seven years of Computer System Validation (CSV) experience in cGMP pharmaceutical or biopharmaceutical environments is required.
  • Deep knowledge of FDA regulations, including 21 CFR Part 11 and 21 CFR Part 820, GAMP 5, and risk-based computer software assurance is required.
  • Experience validating domain- and process-controlled systems, building monitoring and alarm systems, historians, and test automation tools or frameworks is required.
  • Experience with laboratory analytical instrument qualification and cloud-based validation is required.
  • Strong knowledge of data integrity practices, including MHRA and PIC/S guidance, is required.
  • Working knowledge of FDA, EU, and ICH regulations, as well as experience supporting regulatory inspections, is required.
  • Excellent communication, technical writing, and time management skills are required.
  • Strong interpersonal and organizational skills, attention to detail, proactive problem-solving, and effective collaboration across all levels of the organization are required.
  • The ability to independently lead multiple CSV projects for complex systems and digital initiatives, manage testing efforts, and ensure compliance is required.

Responsibilities

  • Lead Kriya's Computer System Validation (CSV) program and manage continuous improvement efforts for the program.
  • Implement risk-based computer system validation approaches and methodologies based on GAMP 5, including critical thinking and the computer software assurance (CSA) approach.
  • Provide oversight for the CSV program and contribute to the creation, support, and maintenance of standard operating procedures, work instructions, and forms, including authoring and revising them.
  • Represent CSV on projects and initiatives, and contribute to planning, development, and implementation of computer system validation documentation.
  • Oversee development of validation documentation, including System Impact Assessments, User Requirements Specifications, Validation Plans, Risk Assessments, Test Protocols, and other deliverables, in accordance with CSV procedures and the CSA approach to testing.
  • Review and audit computer system validation deliverables for compliance with 21 CFR Part 11, Annex 11, and other regulatory requirements.
  • Ensure data integrity assessments are executed and gaps identified through validation testing or procedural controls are resolved or mitigated.
  • Partner with Business Owners and Quality to ensure data integrity controls are effective and compliant.
  • Review and approve change control activities for computerized systems.
  • Own and maintain the computerized system inventory.
  • Provide CSV oversight for manufacturing-related systems, including domain- and process-controlled systems, building monitoring and alarm systems, and process historians.
  • Partner with Automation, Manufacturing, and Facilities to validate computerized systems supporting GMP production, utilities, and building management.
  • Ensure manufacturing systems maintain a validated state through implementation, change control, periodic review, and retirement.
  • Review and approve periodic review activities for computerized systems.
  • Provide leadership and guidance to cross-functional teams to achieve company objectives and team goals, supporting on-time completion of system go-lives and enhancements.
  • Oversee creation and authoring of standard operating procedures, policies, and the validation master plan as needed for the CSV program.
  • Oversee contract validation support.

About the Company

Kriya Therapeutics

Develops gene therapies; licenses collaborations

Kriya Therapeutics develops gene therapies for widespread diseases and monetizes these programs through licensing and collaboration agreements. Its gene therapies target genetic or biological drivers of conditions such as Geographic Atrophy, Diabetic Retinopathy, and NASH, with a focus on ophthalmology. The company advances programs by partnering with biotech and pharma companies to secure upfront payments, milestones, and potential royalties. Its goal is to become a leading gene therapy biopharmaceutical company by delivering safe, effective treatments and generating revenue through collaborations and eventual product sales.

Company size
201-500
Company stage
Series D
Total funding
$920.5M
Headquarters
Morrisville, NC
Founded
2019

Recently Posted Jobs

Explore more opportunities at Kriya Therapeutics

See more jobs